4//SEC Filing
Debrabandere Lode 4
Accession 0001179110-12-005801
CIK 0001360886other
Filed
Mar 26, 8:00 PM ET
Accepted
Mar 27, 2:27 PM ET
Size
7.4 KB
Accession
0001179110-12-005801
Insider Transaction Report
Form 4
Debrabandere Lode
Vice President
Transactions
- Award
Non-Qualified Stock Option (right to buy)
2012-03-23$5.08/sh+12,498$63,490→ 230,000 totalExercise: $5.08From: 2013-03-23Exp: 2022-03-22→ Common Stock (12,498 underlying) - Award
Incentive Stock Option (right to buy)
2012-03-23$5.08/sh+12,502$63,510→ 217,502 totalExercise: $5.08From: 2013-03-23Exp: 2022-03-23→ Common Stock (12,502 underlying)
Footnotes (1)
- [F1]Options to purchase 25,000 shares of the common stock of the Registrant shall become exercisable with respect to the underlying shares as to 25% on each March 23, 2013, 2014, 2015 and 2016, assuming the Reporting Person continues to be employed by the Registrant on the vesting date.
Documents
Issuer
OSIRIS THERAPEUTICS, INC.
CIK 0001360886
Entity typeother
Related Parties
1- filerCIK 0001370936
Filing Metadata
- Form type
- 4
- Filed
- Mar 26, 8:00 PM ET
- Accepted
- Mar 27, 2:27 PM ET
- Size
- 7.4 KB